These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23103739)

  • 1. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
    Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
    FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
    Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
    Zhang HS; Sang WW; Wang YO; Liu W
    J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
    Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
    Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity.
    Tan J; Fan L; Mao JJ; Chen B; Zheng L; Zhang T; Li T; Duan J; Duan Y; Jin Z; Kuang W
    J Cell Biochem; 2012 Sep; 113(9):2903-8. PubMed ID: 22531959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
    Zhang HS; Ruan Z; Sang WW
    J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
    Zhang HS; Wu MR
    Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
    Tabuchi T; Satoh M; Itoh T; Nakamura M
    Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Zhang HS; Sang WW; Ruan Z; Wang YO
    Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
    Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
    Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1.
    Li N; Muthusamy S; Liang R; Sarojini H; Wang E
    Mech Ageing Dev; 2011 Mar; 132(3):75-85. PubMed ID: 21216258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
    Harhaj E; Blaney J; Millhouse S; Sun SC
    Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 regulates HIV transcription via Tat deacetylation.
    Pagans S; Pedal A; North BJ; Kaehlcke K; Marshall BL; Dorr A; Hetzer-Egger C; Henklein P; Frye R; McBurney MW; Hruby H; Jung M; Verdin E; Ott M
    PLoS Biol; 2005 Feb; 3(2):e41. PubMed ID: 15719057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
    Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
    Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.